UBS Group’s Globavend GVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$730 Sell
152
-3,649
-96% -$14.3K ﹤0.01% 9737
2026
Q1
$8.48K Buy
3,801
+2,876
+311% +$3.45K ﹤0.01% 8505
2025
Q4
$1.33K Sell
925
-34
-4% -$146 ﹤0.01% 9623
2025
Q3
$4.4K Buy
+959
New +$6.81K ﹤0.01% 8953
2025
Q2
Sell
-153
Closed -$17.2K 10490
2025
Q1
$17.2K Buy
153
+37
+32% +$5.18K ﹤0.01% 8329
2024
Q4
$15.6K Buy
116
+30
+35% +$4.4K ﹤0.01% 8039
2024
Q3
$14.2K Sell
86
-1,107
-93% -$154K ﹤0.01% 7552
2024
Q2
$210K Buy
1,193
+1,192
+119,200% +$296K ﹤0.01% 5626
2024
Q1
$278 Buy
+1
New +$221 ﹤0.01% 8660

Other funds holding GVH

UBS Group's GVH Position: Q2 2026 in Review

UBS Group reduced its Globavend (GVH) stake by 96% in Q2 2026, selling an estimated $14.3K and leaving 152 shares worth $730. The position accounts for ﹤0.01% of the portfolio, ranked #9737.

UBS Group first reported a position in GVH in Q1 2024 and has held it in 9 quarters since. The position peaked at $210K in Q2 2024. 4 funds tracked by Wall St. Rank hold GVH as of Q2 2026.

  • UBS Group held 152 shares of Globavend worth $730 as of Q2 2026.
  • UBS Group sold 3,649 Globavend shares in Q2 2026, an estimated $14.3K.
  • Globavend made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9737 holding.
  • UBS Group first reported a position in Globavend in Q1 2024 and has held it in 9 quarters since.
  • UBS Group's Globavend position peaked at $210K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Globavend as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.